GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (STU:NL0) » Definitions » Beneish M-Score

GRAIL (STU:NL0) Beneish M-Score : -2.10 (As of Mar. 03, 2025)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.1 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for GRAIL's Beneish M-Score or its related term are showing as below:

STU:NL0' s Beneish M-Score Range Over the Past 10 Years
Min: -2.1   Med: -2.1   Max: -2.1
Current: -2.1

During the past 5 years, the highest Beneish M-Score of GRAIL was -2.10. The lowest was -2.10. And the median was -2.10.


GRAIL Beneish M-Score Historical Data

The historical data trend for GRAIL's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Beneish M-Score Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Beneish M-Score
- - - - -2.10

GRAIL Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -2.10

Competitive Comparison of GRAIL's Beneish M-Score

For the Diagnostics & Research subindustry, GRAIL's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GRAIL's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GRAIL's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where GRAIL's Beneish M-Score falls into.



GRAIL Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of GRAIL for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.658+0.528 * 1.6657+0.404 * 0.7414+0.892 * 1.352+0.115 * 1.0655
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7501+4.679 * 0.007724-0.327 * 0.7415
=-2.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was €19.4 Mil.
Revenue was 36.531 + 25.815 + 29.7 + 24.583 = €116.6 Mil.
Gross Profit was -15.249 + -20.032 + -16.64 + -20.156 = €-72.1 Mil.
Total Current Assets was €783.0 Mil.
Total Assets was €2,849.1 Mil.
Property, Plant and Equipment(Net PPE) was €129.3 Mil.
Depreciation, Depletion and Amortization(DDA) was €108.7 Mil.
Selling, General, & Admin. Expense(SGA) was €341.1 Mil.
Total Current Liabilities was €73.5 Mil.
Long-Term Debt & Capital Lease Obligation was €52.4 Mil.
Net Income was -92.698 + -113.245 + -1472.778 + -153.047 = €-1,831.8 Mil.
Non Operating Income was 0.552 + -0.505 + -1320.045 + 0.039 = €-1,320.0 Mil.
Cash Flow from Operations was -89.283 + -94.227 + -159.601 + -190.703 = €-533.8 Mil.
Total Receivables was €21.8 Mil.
Revenue was 27.809 + 19.417 + 20.688 + 18.347 = €86.3 Mil.
Gross Profit was -17.102 + -25.364 + -22.409 + -23.923 = €-88.8 Mil.
Total Current Assets was €143.1 Mil.
Total Assets was €3,589.0 Mil.
Property, Plant and Equipment(Net PPE) was €155.3 Mil.
Depreciation, Depletion and Amortization(DDA) was €147.2 Mil.
Selling, General, & Admin. Expense(SGA) was €336.3 Mil.
Total Current Liabilities was €150.0 Mil.
Long-Term Debt & Capital Lease Obligation was €63.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(19.398 / 116.629) / (21.804 / 86.261)
=0.166322 / 0.252768
=0.658

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-88.798 / 86.261) / (-72.077 / 116.629)
=-1.029411 / -0.618002
=1.6657

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (782.967 + 129.339) / 2849.058) / (1 - (143.112 + 155.322) / 3588.967)
=0.679787 / 0.916847
=0.7414

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=116.629 / 86.261
=1.352

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(147.233 / (147.233 + 155.322)) / (108.734 / (108.734 + 129.339))
=0.486632 / 0.456725
=1.0655

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(341.11 / 116.629) / (336.325 / 86.261)
=2.924744 / 3.898923
=0.7501

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((52.411 + 73.463) / 2849.058) / ((63.821 + 150.03) / 3588.967)
=0.044181 / 0.059586
=0.7415

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1831.768 - -1319.959 - -533.814) / 2849.058
=0.007724

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

GRAIL has a M-score of -2.06 suggests that the company is unlikely to be a manipulator.


GRAIL Business Description

Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.

GRAIL Headlines

No Headlines